NLS imaging using the Biophilia Intruder scanner is a diagnostic method for breast cancer (BC)
Breast cancer (BC) ranks first among female malignancies. According to the World Health Organization (WHO) expert assessment, by 2015, there will be 1 to 1.5 million new breast cancer patients worldwide each year. The number of women with other benign pathological processes requiring treatment and monitoring will be 25 to 30 times higher than women with breast cancer. Diagnosing breast diseases, including cancer, is the main goal.
Combining an introduction to clinical practice with modern X-ray, ultrasound and radiology equipment, and a new diagnostic method, three-dimensional (3D) virtual NLS-contrast, we can now perform a combined examination of female patients to diagnose breast disease.
Imaging of NLS with the Biophilia Intruder scanner can be considered as a screening diagnostic method and a newer diagnostic method (when ultrascanning and SEA are used) to address controversial issues regarding strategy and treatment of breast lesions. 3D NLS imaging allows us to obtain 3D images of the overall structure of the breast and slices in any plane, the axillary region with lymph nodes, the posterior breast space with all layers of the chest wall, and to differentiate retrosternal lymph nodes. Three-dimensional NLS studies can detect changes in the mammary gland during various pathological processes, determining their size, form, and structure.
NLS-Ultramicroscopy allows us to perform accurate hierarchical visualization of glandular structures (skin, subcutaneous tissue, glands, connective and adipose tissue, blood vessels).
SEA can identify morphological features of tumors through its spectral similarity to the etalon process, assess metastatic invasion of lymph nodes, identify the presence and characteristic genetic aberrations in tumor subclones, and ultimately determine the extent of surgical intervention.
The series of products such as Biophilia Intruder are more and more rich in the direction of diagnosis of diseases.